TC BioPharm (Holdings) PLC (TCBP)
0.6298
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
0.62
-0.01
(-1.56%)
After-Hours: 07:27
TC BioPharm Enterprise Value: -0.927M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -0.927M |
| November 20, 2024 | -0.9269M |
| November 19, 2024 | -0.9441M |
| November 18, 2024 | -0.9363M |
| November 15, 2024 | -0.9111M |
| November 14, 2024 | -0.9176M |
| November 13, 2024 | -0.7829M |
| November 12, 2024 | -0.6797M |
| November 11, 2024 | -0.7044M |
| November 08, 2024 | -0.6747M |
| November 07, 2024 | -0.6648M |
| November 06, 2024 | -0.6549M |
| November 05, 2024 | -0.6006M |
| November 04, 2024 | -0.5511M |
| November 01, 2024 | -0.5907M |
| October 31, 2024 | -0.5857M |
| October 30, 2024 | -0.5808M |
| October 29, 2024 | -0.4374M |
| October 28, 2024 | -0.3978M |
| October 25, 2024 | -0.4473M |
| October 24, 2024 | -0.2593M |
| October 23, 2024 | -0.1506M |
| October 22, 2024 | 0.0472M |
| October 21, 2024 | -0.1159M |
| October 18, 2024 | 1.264M |
| Date | Value |
|---|---|
| October 17, 2024 | 1.293M |
| October 16, 2024 | 1.274M |
| October 15, 2024 | 1.278M |
| October 14, 2024 | 1.254M |
| October 11, 2024 | 1.293M |
| October 10, 2024 | 1.298M |
| October 09, 2024 | 1.224M |
| October 08, 2024 | 1.284M |
| October 07, 2024 | 1.644M |
| October 04, 2024 | 2.515M |
| October 03, 2024 | 2.030M |
| October 02, 2024 | 1.689M |
| October 01, 2024 | 1.284M |
| September 30, 2024 | 1.363M |
| September 27, 2024 | 1.422M |
| September 26, 2024 | 1.664M |
| September 25, 2024 | 1.852M |
| September 24, 2024 | 1.887M |
| September 23, 2024 | 1.842M |
| September 20, 2024 | 1.822M |
| September 19, 2024 | 1.842M |
| September 18, 2024 | 2.05M |
| September 17, 2024 | 2.149M |
| September 16, 2024 | 2.263M |
| September 13, 2024 | 2.006M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.522M
Minimum
Dec 28 2022
66.43M
Maximum
Feb 11 2022
6.749M
Average
1.972M
Median
Mar 18 2024
Enterprise Value Benchmarks
| Adaptimmune Therapeutics PLC | 26.67M |
| Biodexa Pharmaceuticals PLC | -3.355M |
| Verona Pharma PLC | 2.882B |
| NuCana PLC | -11.87M |
| Autolus Therapeutics PLC | 98.72M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.213M |
| Total Expenses (Quarterly) | 4.365M |
| EPS Diluted (Quarterly) | -27.90 |
| Earnings Yield | -437.4K% |